Metabolic Risks of Second Generation Antipsychotics
Author Information
Author(s): Tarricone Ilaria, Casoria Michela, Gozzi Beatrice Ferrari, Grieco Daniela, Menchetti Marco, Serretti Alessandro, Ujkaj Manjola, Pastorelli Francesca, Berardi Domenico
Primary Institution: Institute of Psychiatry, Bologna University
Hypothesis
This study aimed to evaluate the metabolic risk factor profile associated with the use of second generation antipsychotics (SGAs) compared to non-treated control patients.
Conclusion
Patients treated with SGAs had higher rates of obesity and metabolic disorders compared to the control group, indicating a need for routine monitoring of metabolic health in psychiatric patients.
Supporting Evidence
- Patients treated with SGAs had significantly higher mean glycaemia and triglyceridaemia levels than the reference group.
- The prevalence of hyperglycaemia was significantly higher in SGA-treated patients compared to the reference group.
- Patients on clozapine had a significantly higher mean BMI and rate of obesity than those treated with other SGAs.
- Routine monitoring of weight, fasting plasma glucose, cholesterol, and triglyceride levels is recommended for all antipsychotic treatments.
Takeaway
People taking certain mental health medications might gain weight and have higher blood sugar and fat levels, so doctors should check these things regularly.
Methodology
This was an open-label, cross-sectional study comparing metabolic profiles of patients treated with SGAs to a reference group of non-psychiatric outpatients.
Potential Biases
The reference group was not matched for body composition, which may affect the comparison.
Limitations
The study's small sample size and cross-sectional design limit the ability to determine causal relationships between SGA use and metabolic disorders.
Participant Demographics
The study included 76 patients treated with SGAs (38 males, 38 females) and a reference group of 36 subjects (19 females, 17 males).
Statistical Information
P-Value
0.0129
Confidence Interval
95% CI 1.00–62.70
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website